Device type · CFR
Hexokinase, Glucose
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
CFR
Clinical Chemistry
Device class
Class II
FDA decisions since 2015
7
510(k), De Novo and PMA
Adverse event reports
24
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Hexokinase, Glucose
- Product code
- CFR
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1345
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for CFR
Latest FDA decisions
K253490 · Decided Feb 12, 2026 · 111 days after receipt
Device type: Hexokinase, Glucose (CFR) · Laboratory Medicine & Pathology
- Glucose2510(k)
K252357 · Decided Oct 24, 2025 · 87 days after receipt
Device type: Hexokinase, Glucose (CFR) · Laboratory Medicine & Pathology
K220134 · Decided Sep 16, 2022 · 241 days after receipt
Device type: Hexokinase, Glucose (CFR) · Laboratory Medicine & Pathology
K191899 · Decided Aug 16, 2019 · 31 days after receipt
Device type: Hexokinase, Glucose (CFR) · Laboratory Medicine & Pathology
K170316 · Decided Oct 19, 2017 · 260 days after receipt
Device type: Hexokinase, Glucose (CFR) · Laboratory Medicine & Pathology
K153644 · Decided Sep 7, 2016 · 261 days after receipt
Device type: Hexokinase, Glucose (CFR) · Laboratory Medicine & Pathology
- Diatron Pictus 700 Clinical Chemistry Analyzer, Diatron ISE, Diatron Glucose Hexokinase Method510(k)
K151487 · Decided Jan 14, 2016 · 226 days after receipt
Device type: Hexokinase, Glucose (CFR) · Laboratory Medicine & Pathology
Reports received
24
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
24
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 3 | 0 | 0 | 0 |
| Jan 24 | 1 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 3 | 0 | 0 | 0 |
| May 24 | 1 | 0 | 0 | 0 |
| Jun 24 | 1 | 0 | 0 | 0 |
| Jul 24 | 3 | 0 | 0 | 0 |
| Aug 24 | 3 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 2 | 0 | 0 | 0 |
| Nov 24 | 1 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 1 | 0 | 0 | 0 |
| Feb 25 | 5 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 1 | 0 | 0 | 0 |
| May 25 | 3 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 2 | 0 | 0 | 0 |
| Oct 25 | 1 | 0 | 0 | 0 |
| Nov 25 | 1 | 0 | 0 | 0 |
| Dec 25 | 2 | 0 | 0 | 0 |
| Jan 26 | 2 | 0 | 0 | 0 |
| Feb 26 | 3 | 0 | 0 | 0 |
| Mar 26 | 1 | 0 | 0 | 0 |
| Apr 26 | 4 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 2 | 0 | 0 | 0 |
| Jul 26 | 3 | 0 | 0 | 0 |
| Aug 26 | 4 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 2 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Non Reproducible Results8
- High Test Results6
- Incorrect Measurement4
- Low Test Results3
- Incorrect, Inadequate or Imprecise Result or Readings2
- Insufficient Device Problem Information1
- Output Problem1
- Wrong Label1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions24
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Siemens Healthcare Diagnostics, Inc.
Z-1652-2018 · Started Jun 29, 2017
Reason given: Various assays used to measure different chemical levels in blood, urine, or cerebrospinal fluid may interfere with the drugs sulfasalazine and/or sulfapyridine causing falsely elevated or falsely depressed results.
Cause as FDA categorized it: Device Design
Siemens Healthcare Diagnostics, Inc.
Z-1658-2018 · Started Jun 29, 2017
Reason given: Various assays used to measure different chemical levels in blood, urine, or cerebrospinal fluid may interfere with the drugs sulfasalazine and/or sulfapyridine causing falsely elevated or falsely depressed results.
Cause as FDA categorized it: Device Design
Z-0740-2016 · Started Jan 11, 2016 · Posted by FDA Feb 2, 2016
Reason given: N-Acetylcysteine (NAC) present in the blood of patients treated for paracetamol overdose can interfere with the Trinder reaction that uses hydrogen peroxide catalytic on aminoantipyrine and phenol, and can produce falsely low results with the reagents using the Trinder reaction method.
Cause as FDA categorized it: Under Investigation by firm
- Glucose Hexokinase (Liquid) Reagent For the in vitro quantitative determination of Glucose in serum.Terminated
Z-0827-2015 · Started Oct 23, 2014 · Posted by FDA Dec 18, 2014
Reason given: Product is not performing according to specifications. Control 2 does not consistently recover within its assigned range.
Cause as FDA categorized it: Under Investigation by firm
Mindray DS USA, Inc. d.b.a. Mindray North America
Z-0977-2013 · Started Nov 28, 2012 · Posted by FDA Mar 22, 2013
Reason given: An issue has been identified with the BS-200 where clinical chemistry results may be inaccurate.
Cause as FDA categorized it: Device Design
Z-0104-2010 · Started Oct 19, 2009 · Posted by FDA Nov 4, 2009
Reason given: There is a loss of linearity. The product fails to maintain linearity specification of 500 mg/dL.
Cause as FDA categorized it: Process design
Z-0219-2009 · Started Sep 10, 2008 · Posted by FDA Oct 31, 2008
Reason given: The inability of the product to maintain stated performance specifications through the stated shelf life.
Cause as FDA categorized it: Process control
Z-0220-2009 · Started Sep 10, 2008 · Posted by FDA Oct 31, 2008
Reason given: The inability of the product to maintain stated performance specifications through the stated shelf life.
Cause as FDA categorized it: Process control
Showing the 8 newest of 22 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.